Cargando…

Role of presynaptic calcium stores for neural network dysfunction in Alzheimer's disease

Detalles Bibliográficos
Autores principales:	Lerdkrai, Chommanad, Garaschuk, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022463/ https://www.ncbi.nlm.nih.gov/pubmed/29926819 http://dx.doi.org/10.4103/1673-5374.233435

Ejemplares similares

Prevalence of the MDR1 gene mutation in herding dog breeds and Thai Ridgebacks in Thailand
por: Lerdkrai, Chommanad, et al.
Publicado: (2021)

A novel multiplex polymerase chain reaction assay for the genotypic survey of the non-homologous end-joining factor 1 gene associated with Collie eye anomaly in Thailand
por: Lerdkrai, Chommanad, et al.
Publicado: (2022)

Olfactory dysfunction as a common biomarker for neurodegenerative and neuropsychiatric disorders
por: Slabik, David, et al.
Publicado: (2022)

The role of NLRP3 inflammasome for microglial response to peripheral inflammation
por: Garaschuk, Olga
Publicado: (2020)

Intracellular calcium signalling in Alzheimer’s disease
por: Hermes, Marina, et al.
Publicado: (2010)

Emerging role of lysosomal calcium store as a hub of neuroprotection
por: Tedeschi, Valentina, et al.
Publicado: (2021)

The Interplay between cGMP and Calcium Signaling in Alzheimer’s Disease
por: Jehle, Aileen, et al.
Publicado: (2022)

Role of serotonin in modulating the development and function of adult-born neurons in the olfactory bulb
por: Fomin-Thunemann, Natalie, et al.
Publicado: (2021)

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

Suppression of Store-operated Calcium Entry Channels and Cytokine Release by Cannabinoids
por: Kozak, J Ashot
Publicado: (2022)

Reduced presynaptic vesicle stores mediate cellular and network plasticity defects in an early-stage mouse model of Alzheimer’s disease
por: Chakroborty, Shreaya, et al.
Publicado: (2019)

Defective autophagy and Alzheimer’s disease: is calcium the key?
por: Filadi, Riccardo, et al.
Publicado: (2019)

TDP-43 overexpression impairs presynaptic integrity
por: Heyburn, Lanier, et al.
Publicado: (2016)

GABAergic astrocytes in Alzheimer’s disease
por: Garaschuk, Olga, et al.
Publicado: (2019)

Presynaptic endoplasmic reticulum architecture and hereditary spastic paraplegia
por: Pérez-Moreno, Juan José
Publicado: (2023)

Calcium handling: a strategy to fight neurodegeneration in Alzheimer’s disease
por: La Barbera, Livia, et al.
Publicado: (2023)

Presynaptic Calcium Channels
por: Mochida, Sumiko
Publicado: (2019)

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023)

APP accumulates with presynaptic proteins around amyloid plaques: A role for presynaptic mechanisms in Alzheimer's disease?
por: Jordà‐Siquier, Tomàs, et al.
Publicado: (2022)

Activity dependent modulation of synaptic transmission by presynaptic calcium stores: A dichotomy of short-term depression and facilitation
por: Nadkarni, Suhita, et al.
Publicado: (2013)

Insights from human sleep research on neural mechanisms of Alzheimer’s disease
por: Cordone, Susanna, et al.
Publicado: (2020)

Probiotics, prebiotics and their role in Alzheimer’s disease
por: D'Argenio, Valeria, et al.
Publicado: (2021)

Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store
por: Thibault, Olivier, et al.
Publicado: (2007)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery
por: Bennett, David A.
Publicado: (2017)

Rogue gene networks gone awry in Alzheimer's disease
por: Miyoshi, Emily, et al.
Publicado: (2021)

Hemoglobin Oxidation Reactions in Stored Blood
por: Alayash, Abdu I.
Publicado: (2022)

Computer-Based Drug Design of Positive Modulators of Store-Operated Calcium Channels to Prevent Synaptic Dysfunction in Alzheimer’s Disease
por: Hunanyan, Lernik, et al.
Publicado: (2021)

Beta‐amyloid pore linked to controlled calcium influx into the cell: A new paradigm for Alzheimer's Disease
por: Pannuzzo, Martina
Publicado: (2021)

Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer’s disease and other tauopathies
por: Florenzano, Fulvio, et al.
Publicado: (2017)

Presynaptic Dysfunction by Familial Factors in Parkinson Disease
por: Lee, Wongyoung, et al.
Publicado: (2018)

Streptozotocin induced Alzheimer's disease like changes and the underlying neural degeneration and regeneration mechanism
por: Kamat, Pradip Kumar
Publicado: (2015)

Role and limitations of rehabilitation-induced neural network remodeling after stroke
por: Okabe, Naohiko, et al.
Publicado: (2018)

The Role of Long Noncoding RNAs in Diabetic Alzheimer’s Disease
por: Kim, Young-Kook, et al.
Publicado: (2018)

Neural and Neurobehavioral Dysfunction in Children with Obstructive Sleep Apnea
por: Beebe, Dean W
Publicado: (2006)

Presynaptic inhibition and neural control /

Brain network modulation in Alzheimer’s disease: clinical phenotypes and windows of opportunity
por: Pini, Lorenzo
Publicado: (2022)

Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer’s disease
por: Shah, Disha, et al.
Publicado: (2022)

Detrimental and synergistic role of epilepsy – Alzheimer’s disease risk factors
por: Filippov, Mikhail A., et al.
Publicado: (2019)

Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases
por: Sambri, Irene, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kd6c6rnssv7jro7vtiaf9eaplm